Borgeson Blake

Director

1 company

Strong

Trades Analyzed

12M Win Rate

69.6%

Avg 3M Return

+3.4%

Avg 12M Return

+12.4%

Borgeson Blake is a Director at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 12 sells.

Estimated insider holdings value: $21.1M based on current market prices.

Holdings by Company

RXRXJan 6, 2026

Current Shares6.65M

Value$21.15M

Net Activity-1,101,585

Bought: 0Sold: 1.10M

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 5, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	20,054	$12.06	$241,805.12	-0.3%	-27.9%	-44.8%
Feb 20, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	20,054	$12.32	$247,124.87	-0.1%	-22.3%	-13.7%
Feb 6, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$9.30	$106,489.15	-0.2%	-5.7%	-16.5%
Jan 23, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	20,054	$10.58	$212,083.08	-0.3%	-28.6%	-29.6%
Jan 9, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	20,054	$13.62	$273,202.44	-0.1%	-32.8%	-45.8%
Dec 26, 2023	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	20,054	$10.63	$213,143.94	-0.3%	-2.4%	-29.0%
Dec 12, 2023	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$7.40	$84,692.92	-0.2%	+39.4%	+1.7%
Nov 28, 2023	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$6.72	$76,918.12	-0.2%	+110.3%	-9.1%
Nov 14, 2023	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	8,885	$6.32	$56,150.53	-0.1%	+69.3%	+13.3%
Oct 31, 2023	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	8,885	$5.27	$46,863.93	-0.1%	+103.8%	+26.5%